Protocol Collaboration with the NIH

The NGLY1 community is very fortunate to collaborate with the National Institutes of Health (NIH) in Bethesda, Maryland, USA, where several NGLY1 patients are being seen under two important protocols gaining valuable insights into the characteristic symptoms and natural progression of the disease and laying the groundwork for future therapeutic approaches.

For more information on this project, email